Biogen Inc

XTER : IDP
USA·Healthcare·Drug Manufacturers
€160.15
+2.50 (+1.59%)latest daily quote
Market Cap
€23.50B
Enterprise Value
€25.88B
P/E (TTM)
21.56
P/B
1.53
Net Cash / (Debt)
−€2.36B
52-Week Range
€126 — €168
5-Year Range
€99 — €297
Avg Volume (3M)
887
ListingsXTERLTSNAS
Biogen Inc has no dividend payments on record. Any capital returned to shareholders comes through share repurchases — shown below.

Capital returns

Net buybacks = repurchases − stock issuance, fiscal-year cash flows. SBC shown for dilution context.

Total Shareholder Yield (TTM)
0.0%
Dividends 0.0% + Net buybacks 0.0%
Net Buyback (TTM)
€0
Gross €0 − Issuance €0
SBC (TTM)
€255M
Share-based compensation, dilution driver
Net share-count change % / yr
No splits on record.